
Oak Street Health is owned by CVS Health Corporation (NYSE: CVS), the integrated healthcare company headquartered in Woonsocket, Rhode Island. CVS acquired Oak Street Health in May 2023 for approximately $10.6 billion. Founded in 2012 in Chicago, Oak Street operates about 230 value-based primary care centers across 27 states serving roughly 350,000 Medicare-eligible patients.
Parent Company
Acquired
2023
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Oak Street Health | CVS Health Corporation | Subsidiary |
Mike Pykosz, Geoff Price, and Griffin Myers founded Oak Street Health in Chicago in 2012. All three came from healthcare consulting backgrounds, including work at the Boston Consulting Group, and they built the company around a specific observation: Medicare patients in underserved neighborhoods received fragmented, reactive care, and a primary care model that took financial responsibility for keeping patients healthy could outperform fee-for-service medicine.
The first center opened in 2013 in the Edgewater neighborhood on Chicago's north side. The model placed clinics deliberately in areas with too few primary care providers, accepted Medicare and Medicare Advantage patients, and paid clinicians to manage outcomes rather than volume. Centers combined medical care with behavioral health and social support, and community rooms hosted events that kept patients connected between visits.
Growth was deliberate at first, then accelerated with venture funding from investors including General Atlantic and Newlight Partners. Oak Street expanded across the Midwest and into Texas, Pennsylvania, and other states. By 2020, the company operated about 60 centers.
In August 2020, Oak Street Health went public on the NYSE at $21 per share, one of the year's larger healthcare IPOs, and used the capital to speed expansion past 100 centers. The company also struck a notable partnership with AARP, becoming the only primary care provider to carry the AARP name on its centers.
CVS Health announced the acquisition in February 2023 and closed it in May 2023 for approximately $10.6 billion, at the time its largest healthcare services deal since Aetna. CVS said it aimed to grow Oak Street from about 169 centers to 300 or more by 2026.
Reality fell short of that plan. Medicare Advantage medical costs rose sharply across the industry in 2024 and 2025, pressuring value-based care economics. CVS expanded Oak Street to 246 centers but announced in late 2025 that it would close 16 locations by the end of February 2026 and temper its growth trajectory. As of September 2026, the network stands at about 230 centers in 27 states with roughly 350,000 patients, 8,500 employees, and nearly 900 primary care providers.
What does CVS Health own?
CVS Health owns CVS Pharmacy (nearly 10,000 retail locations), CVS Caremark (pharmacy benefits management), Aetna (health insurance), MinuteClinic (retail health clinics), Oak Street Health (Medicare primary care), Omnicare (long-term care pharmacy), Navarro Discount Pharmacies, Longs Drugs, and Coram (infusion and home health services). These brands operate across three segments: Health Care Benefits, Health Services, and Pharmacy and Consumer Wellness.
Is CVS Health publicly traded?
Yes. CVS Health Corporation is publicly traded on the New York Stock Exchange under the ticker symbol CVS. The company is a component of the S&P 500 and is owned by institutional investors, mutual funds, and individual shareholders. There is no parent company or controlling shareholder.
Who founded CVS Health?
The original Consumer Value Store was founded in 1963 in Lowell, Massachusetts by Stanley Goldstein, Sidney Goldstein, and Ralph Hoagland. The company began as a health and beauty products retailer and added pharmacy departments in 1967. It was acquired by Melville Corporation in 1969 and spun off as an independent public company in 1996.
Where is CVS Health headquartered?
CVS Health is headquartered in Woonsocket, Rhode Island, USA. The company's corporate offices, including executive leadership, finance, and strategic operations, are based in Woonsocket, with additional operational offices across the United States.
How many brands does CVS Health own?
CVS Health owns approximately 9 brands across its three operating segments. The most prominent are CVS Pharmacy, CVS Caremark, Aetna, MinuteClinic, Oak Street Health, and Omnicare. The company also operates smaller regional brands including Navarro Discount Pharmacies and Longs Drugs.
Who owns CVS Health?
CVS Health is an independent publicly traded corporation with no parent company. The company is owned by institutional investors, mutual funds, and individual shareholders who hold its NYSE-listed common stock. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation. There is no founder control or dual-class share structure.
What were CVS Health's recent financial results?
For FY2025, CVS Health reported record revenue of $402.1 billion, up 7.8% year over year, and adjusted EPS of $6.75. In Q2 2026, revenue was $106.1 billion, up 7.3%, with adjusted EPS of $2.58, beating analyst estimates of $1.85. Net income nearly tripled to $3 billion. The company raised its 2026 guidance to at least $414 billion in revenue and adjusted EPS of $7.90 to $8.10.
Has CVS Health made major acquisitions recently?
The most recent major acquisitions were Oak Street Health for approximately $10.6 billion and Signify Health for approximately $8 billion, both in 2023. The largest acquisition in company history was Aetna for approximately $69 billion in 2018. CEO David Joyner has indicated the company has the capital and leadership bandwidth to pursue additional deals across its three business areas.
Oak Street Health's controversies center on the economics of Medicare-focused primary care rather than product failures. In 2023, before the CVS acquisition closed, Oak Street paid $60 million to resolve a U.S. Department of Justice False Claims Act investigation alleging the company paid kickbacks to insurance agents who referred seniors to its clinics.
Investor suits around the CVS acquisition price also surfaced, though the deal closed as announced. More broadly, critics of Medicare Advantage-aligned primary care, including academic researchers and some policymakers, argue that full-risk models create incentives to underprovide care or to over-document patient severity to raise payments. Oak Street maintains its model increases preventive visits and reduces hospitalizations, supported by its 44% admissions reduction claim.
The 2025 announcement of 16 clinic closures drew criticism from patient advocates in affected neighborhoods, where the centers had been marketed as anchors for underserved communities. CVS said the closures reflect market conditions and that the remaining 230-center network continues operating.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Humana | USA | 2022 | Market leader | United states | Seniors-65-plus | |
| Humana | USA | 2022 | Growth segment | United states | Seniors-65-plus | |
| Centene | USA | 1993 | Market leader | United states | All-ages | |
| Humana | USA | 1985 | Market leader | United states | Seniors-65-plus | |
| Amazon | United States | 2007 | Premium | United states | All-ages | |
| Unitedhealth Group | United States | 2011 | Mass market | United states | All Genders |
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's care-delivery brand combining senior primary care clinics, the nation's largest home health operation, and pharmacy services under a unified healthcare platform.
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's healthcare delivery division, now operating as the CenterWell segment, combining senior primary care, home health, pharmacy, and related care services.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's New York State health plan, founded in 1993 by the Catholic bishops of New York and acquired for $3.75 billion in July 2018, serving more than 2.4 million members.
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's Medicare product line, the second-largest Medicare Advantage insurer in the United States, which grew membership about 20 percent in the 2026 annual enrollment period.
Healthcare PharmaceuticalsOwned by Amazon.com Inc.
Amazon-owned membership-based primary care practice operating nearly 240 offices across more than 20 U.S. markets with 24/7 virtual care.
Healthcare PharmaceuticalsOwned by UnitedHealth Group
UnitedHealth Group's healthcare delivery and value-based care division employing or affiliating with more than 90,000 physicians, generating $105.4 billion in 2024 revenue as one of the largest physician employers in the United States.
Market Positioning: Oak Street Health competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by CVS Health Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Oak Street Health which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.